Global Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market By Sample Type (Blood, Serum, And Plasma, Urine, Other Sample Types), By Product, By Testing Type, By Disease Type, By Technology, By End User, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2341 | Region: Global | Published Date: December, 2025
Pages: 186 |Tables: 187 |Figures: 79

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Infectious Disease Diagnostics Market size was valued at USD 22.94 Billion in 2024 and is poised to grow from USD 24.82 Billion in 2025 to USD 46.63 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026–2033).

    Infectious disease diagnostics providers should focus on increasing the efficacy of their tests and reduce their result times by investing in R&D. Leveraging advanced technologies such as AI and molecular diagnostics is also a prominent opportunity for companies as per this global infectious disease diagnostics market analysis. 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Abbott (US)', 'bioMerieux (France)', 'Siemens Healthineers AG (Germany)', 'Danaher (US)', 'Thermo Fisher Scientific Inc. (US)', 'Hologic, Inc. (US)', 'Becton, Dickinson and Company (US)', 'Revvity (US)', 'Qiagen (Netherlands)', 'Seegene Inc. (South Korea)', 'QuidelOrtho Corporation (US)', 'Grifols, S.A. (Spain)', 'DiaSorin S.p.A. (Italy)', 'Bio-Rad Laboratories, Inc. (US)', 'Sysmex Corporation (Japan)', 'OraSure Technologies (US)', 'Co-Diagnostics, Inc. (US)', 'Trinity Biotech (Ireland)', 'Genetic Signatures Ltd. (Australia)'

    Increase in cases of infectious disease outbreaks in recent years has prompted governments and health NGOs to launch new initiatives to promote disease awareness. Initiatives like WHO’s Global Antimicrobial Resistance Surveillance System (GLASS), CDC campaigns, and funding from organizations like the Gates Foundation significantly support diagnostic deployment in low- and middle-income countries. Such initiatives not only raise awareness but also fund procurement, R&D, and distribution of infectious disease diagnostics.

    Rise of Multiplex and Syndromic Testing Panels: The ability of multiplex and syndromic testing panels to detect multiple pathogens from a single sample is boosting their popualrity. Adoption of such panels is expected to be high for respiratory, gastrointestinal, and sexually transmitted infections. This infectious disease diagnostics market trend is particularly valuable in emergency departments, ICUs, and during outbreaks, where rapid and comprehensive diagnostics are critical. As laboratories prioritize cost-efficiency and workflow optimization, the demand for multiplex molecular panels is slated to rise rapidly through 2032.

    Why is Adoption of Infectious Disease Diagnostics High in North America?

    Related Reports

    Veterinary Infectious Disease Diagnostics Market
    Buy Now GET FREE SAMPLE
    Influenza Diagnostics Market
    Buy Now GET FREE SAMPLE
    Rapid Diagnostics Market
    Buy Now GET FREE SAMPLE
    COVID-19 Diagnostics Market
    Buy Now GET FREE SAMPLE
    Molecular Diagnostics Market
    Buy Now GET FREE SAMPLE
    Autoimmune Disease Diagnostics Market
    Buy Now GET FREE SAMPLE
    Sepsis Diagnostics Market
    Buy Now GET FREE SAMPLE
    Veterinary Diagnostics Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Infectious Disease Diagnostics Market

    Report ID: SQMIG35D2341

    $5,300
    BUY NOW